Response to: 'Different glucosamine sulfate products generate different outcomes on osteoarthritis symptoms' by Reginster et al

Related Experiment Videos

Jos Runhaar¹, Rianne M Rozendaal¹, Marienke van Middelkoop¹

¹Department of General Practice, Erasmus University Medical Center Rotterdam, Rotterdam, Zuid-Holland, Netherlands.

Annals of the Rheumatic Diseases

|September 17, 2017

Abstract

No abstract available in PubMed .

Keywords:

disease activity osteoarthritis treatment

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Trajectories of physical activity following digital education and exercise therapy-a longitudinal registry study among 15,197 persons with knee or hip osteoarthritis.

BMC musculoskeletal disorders·2026

Strengthening health systems to prioritise, provide care, and prevent osteoarthritis: a roadmap for global health policy.

Lancet (London, England)·2026

Integrating deep learning-based radiographic features with demographic variables for hip osteoarthritis prediction: development and validation using individual participant data from the World COACH Consortium.

Osteoarthritis imaging·2026

Changes in health-related quality of life: a longitudinal registry study among over 15,000 participants of a digital education and exercise therapy for knee and hip osteoarthritis using EQ-5D-5L.

Health and quality of life outcomes·2026

Association of analgesics prescription with incident comorbidities in people with osteoarthritis-a UK primary care database cohort study.

Rheumatology advances in practice·2026

Associations between osteoarthritis and comorbidities before and after diagnosis across four European primary care databases: a multinational case-control and cohort study.

The Lancet regional health. Europe·2026

See all related articles